Cargando…
Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance
Chimeric antigen receptor (CAR) transduced T cells have significantly improved cancer immunotherapy. Similarly, engineering regulatory T cells (Treg) with specific receptors to endow specificity and increase efficacy of Tregs holds great promise for therapy of a variety of adverse immune responses....
Autor principal: | Scott, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450509/ https://www.ncbi.nlm.nih.gov/pubmed/34552599 http://dx.doi.org/10.3389/fimmu.2021.742719 |
Ejemplares similares
-
CAR-T cells: the long and winding road to solid tumors
por: D’Aloia, Maria Michela, et al.
Publicado: (2018) -
Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells
por: Pohl, Alessandra De Paula, et al.
Publicado: (2020) -
From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance
por: Scott, David W.
Publicado: (2017) -
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
por: Long, Kristen B., et al.
Publicado: (2018) -
Road testing new CAR design strategies in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2022)